Related Experiment Video
Updated: Aug 7, 2026
Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
In-Silico molecular screening of natural compounds as a potential therapeutic inhibitor for Methicillin-resistant
Palanichamy Nandhini1, Prashant Kr Gupta2, Arun Kumar Mahapatra2
1Biomaterials in Medicinal Chemistry Laboratory, Department of Natural Products Chemistry, School of Chemistry, Madurai Kamaraj University, Madurai-625021, India.
Abstract:
Methicillin-resistant Staphylococcus aureus (MRSA) is a life-threatening superbug causing infectious diseases such as pneumonia, endocarditis, osteomyelitis, etc. Conventional antibiotics are ineffective against MRSA infections due to their resistance mechanism against the antibiotics. The Penicillin Binding Protein (PBP2a) inhibits the activity of antibiotics by hydrolyzing the β-lactam ring. Thus, alternate treatment methods are needed for the treatment of MRSA infections. Natural bioactive compounds exhibit good inhibition efficiency against MRSA infections by hindering its enzymatic mechanism, efflux pump system, etc. The present work deals with identifying potential and non-toxic natural bioactive compounds (ligands) through molecular docking studies through StarDrop software. Various natural bioactive compounds which are effective against MRSA infections were docked with the protein (6VVA). The ligands having good binding energy values and pharmacokinetic and drug-likeness properties have been illustrated as potential ligands for treating MRSA infections. From this exploration, Luteolin, Kaempferol, Chlorogenic acid, Sinigrin, Zingiberene, 1-Methyl-4-(6-methylhepta-1,5-dien-2-yl)cyclohex-1-ene, and Curcumin have found with good binding energies of -8.6 kcal/mol, -8.4 kcal/mol, -8.2 kcal/mol, -7.5 kcal/mol, -7.4 kcal/mol, -7.3 kcal/mol, and -7.2 kcal/mol, respectively.
Insights
Natural compounds show promise in combating Methicillin-resistant Staphylococcus aureus (MRSA) infections. Molecular docking identified several compounds, including Luteolin and Curcumin, as potential treatments against this antibiotic-resistant superbug.
Area of Science:
- Microbiology
- Computational Chemistry
- Pharmacology
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant threat due to widespread antibiotic resistance.
- Conventional antibiotics fail against MRSA due to mechanisms like Penicillin Binding Protein 2a (PBP2a) activity.
- Novel therapeutic strategies are essential to overcome MRSA infections.
Purpose of the Study:
- To identify potential, non-toxic natural bioactive compounds (ligands) effective against MRSA.
- To evaluate the inhibitory potential of these compounds against MRSA's enzymatic mechanisms.
- To utilize molecular docking for predicting drug-likeness and binding affinities.
Main Methods:
- Molecular docking studies were performed using StarDrop software.
- Natural bioactive compounds were docked against the MRSA PBP2a protein target (PDB ID: 6VVA).
- Ligands were screened based on binding energy, pharmacokinetic, and drug-likeness properties.
Main Results:
- Several natural compounds demonstrated significant binding affinities to the target protein.
- Luteolin (-8.6 kcal/mol), Kaempferol (-8.4 kcal/mol), and Chlorogenic acid (-8.2 kcal/mol) exhibited the highest binding energies.
- Other effective compounds included Sinigrin, Zingiberene, 1-Methyl-4-(6-methylhepta-1,5-dien-2-yl)cyclohex-1-ene, and Curcumin.
Conclusions:
- The identified natural compounds represent promising candidates for developing new anti-MRSA therapies.
- These compounds may offer alternative treatment options by targeting key MRSA mechanisms.
- Further research is warranted to validate these findings and explore therapeutic applications.
Related Concept Videos
01:25Mechanism of Antibiotic Resistance in MRSA
01:25Clinical Significance of Antibiotic Resistance